Healthcare industry

Expert interview - 03/03/2021

Healthcare movers – the future of Baden-Württemberg's healthcare industry

The 'Healthcare Movers 2020 - Baden-Württemberg Report' reveals the potentials and challenges Baden-Württemberg healthcare companies encounter as the digital transformation of the healthcare market progresses. In an interview with Dr. Ariane Pott from BIOPRO, the authors of the report, Beatus Hofrichter and Dr. Ursula Kramer, explain what is required to take the major step towards becoming a digital avant-garde company.

Article - 01/06/2017

Biotechnology – key technology of the 21st century

According to a study published by the German National Academy of Science and Engineering (acatech) on 5th April, biotechnology is a key technology of the 21st century and has huge innovation potential. What are the trends within the industry and what are the challenges we face?

Press release - 16/11/2015

The Baden-Württemberg healthcare industry – a strong economic power

(Stuttgart – 16th November 2015) BIOPRO Baden-Württemberg has just published its latest analysis of the Baden-Württemberg healthcare industry including comprehensive facts and figures. Baden-Württemberg continues to be one of the top locations for medical technology, pharma and biotechnology in Germany.

Press release - 01/08/2012

Combination of businesses of SYGNIS and GENETRIX’ subsidiary X-Pol proposed

SYGNIS Pharma AG and GENETRIX announced today, that the biotechnology companies SYGNIS and GENETRIX have signed a binding Term Sheet under which the companies propose to combine the GENETRIX’ DNA sequencing subsidiary X-Pol Biotech and SYGNIS. Goal is to develop and market X-Pol Biotech, S.L.’s DNA sequencing technologies and products.

Press release - 23/05/2012

GlaxoSmithKline to fully acquire Cellzome for 99 million U.S. dollar

GlaxoSmithKline plc (GSK) announced that it has entered into an agreement to acquire those shares it does not currently own in Cellzome, a leader in the development and advancement of proteomics technologies, for £61 million (US$99 million) in cash. Cellzome, a privately owned company with laboratories in Cambridge, UK, and Heidelberg, Germany, will become part of GSK’s R&D organisation.

Press release - 10/05/2012

BVMed propounds Annual Report

The German Medical Technology Association BVMed advocates for a better coordination and promotion of advances in medical technology. BVMed the German Medical Technology Association represents more than 230 manufacturers and trade companies in the medical technology sector. Medtech production amounts to about 20 billion euros with 175.000 employees in Germany.

Press release - 15/11/2011

CureVac, Sanofi Pasteur and In-Cell-Art collaborate on a $33.1 million project

CureVac GmbH today announced the signing of several agreements with Sanofi Pasteur S.A., the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY). Under these agreements, CureVac and Sanofi Pasteur will further develop and apply CureVac’s proprietary RNActive® technology platform to the development of vaccines against several infectious diseases.

Press release - 07/11/2011

Third quarter: HARTMANN increases sales in all business segments

The HARTMANN GROUP continued its growth despite the difficult conditions in the health markets. Global sales revenues increased by 5.0 percent to EUR 1,263.8 million compared to the previous year.

Press release - 03/11/2011

Curetis AG attracts Forbion and Roche as new investors

Curetis AG, an innovative molecular diagnostics company focusing on the development and commercialization of in-vitro diagnostic products for infectious diseases, announced the expansion of its Series A financing round by € 9.6 million. The additional funds increase the round to a total of € 34.1 million and the total capital raised to date to € 36.6 million.

Press release - 24/10/2011

Curetis AG Opens Unyvero™ Cartridge Production Facility

Curetis AG, an innovative molecular diagnostics company focusing on the development and commercialization of in-vitro diagnostic products for infectious diseases, announced the opening of its state-of-the-art production facility for disposable Unyvero™ cartridges in Bodelshausen (near Tuebingen, Germany).

Press release - 10/10/2011

Vetter’s state-of-the-art Chicago facility is fully operational

Vetter, a leading contract development and manufacturing organization that specializes in aseptic filling, today announced that its first U.S. facility is now fully operational. Located at the Illinois Science + Technology Park in suburban Chicago, the 24,000-square-foot site includes microbiology and chemical analysis labs, material preparation and compounding functions, three cleanrooms for aseptic filling, and visual inspection. The first to…

Press release - 05/09/2011

Sequenom announces European licensing agreement with GATC daughter LifeCodexx

Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced it has partnered with LifeCodexx AG, a company focused on the development of clinically validated Next Generation Molecular Diagnostics, for the commercialization of prenatal laboratory testing services in Europe. The companies have agreed to collaborate in the development and launch of a trisomy 21 laboratory developed test…

Press release - 04/08/2011

HARTMANN stands its ground in an increasingly difficult market

In the first half of 2011 the HARTMANN GROUP was confronted with an unfavorable market environment. Raw material and logistics costs continued to rise significantly in the overall economic recovery. Furthermore there has been added price pressure from customers due to the national deficits and the associated budget restrictions in the health systems. Nevertheless HARTMANN succeeded in further increasing sales revenues by 6.2 to EUR 845.3 million…

The Baden-Württemberg Ministry of Finance and Economics presented the results of two studies that evaluated the innovative strength of Baden-Württemberg in comparison to other regions around the world. The studies were carried out by the University of Hohenheim and the independent research institute BAK Basel Economics AG BAK Basel on behalf of the Baden-Württemberg Ministry of Finance and Economics and they were financed by the Baden-Württemberg…

Press release - 20/07/2011

Roche acquires mtm laboratories AG, expanding offering in cervical cancer

Roche announced on July 19th that it has signed an agreement under which it will acquire 100 percent of mtm laboratories AG (mtm), a privately-held company based in Heidelberg, Germany. mtm is a global leader in developing in vitro diagnostics with a focus on early detection and diagnosis of cervical cancer, the largest early detection market in oncology. mtm will become part of Roche’s Tissue Diagnostics (Ventana Medical Systems, Inc.) business…

Press release - 22/06/2011

SYGNIS Pharma AG secures further financial resources with shareholder loan

SYGNIS Pharma AG (Frankfurt: LIOK; ISIN DE000A1E9B74; Prime Standard) today executed a subordinated loan agreement for a total amount of EUR 6 million with its main shareholder dievini Hopp BioTech holding GmbH & Co. KG, Walldorf, Germany (dievini), with an interest-rate at customary market conditions. As a result this loan, which is payable on demand, secures the financing of SYGNIS’ existing operations, according to the present plans, at…

Press release - 17/06/2011

Vetter Invests in Additional Lyophilization Capacity

Vetter, a leading specialist in aseptic filling, has installed three additional state-of-the-art lyophilizers at the company’s Ravensburg Vetter South facility, nearly doubling its number of freeze-dryers. Altogether, the site will be able to produce up to 24 million lyophilized units annually. The new equipment increases the number of lyophilizers across all Vetter facilities by 30 percent.

Press release - 12/06/2011

Interview with Nycomed CEO Hakån Björklund

Nycomed CEO Hakån Björklund talks about the sale of his company to its Japanese competitor Takeda. He believes that the two companies are well-matched in strategic terms. Björklund has been CEO (chief executive officer) of Nycomed since 1999.

Press release - 04/05/2011

Vetter’s Chicago Facility Now Accepting Projects

Vetter, a leading provider of aseptic prefilled drug-delivery systems, announced that its Chicago facility is accepting client projects. Located at the Illinois Science + Technology Park in Skokie, Illinois, the site supports preclinical through phase II products.

SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime Standard) announced today a comprehensive, strategic restructuring of the company, which will include significant personnel and cost reductions. The process has been approved by the Supervisory Board and will be executed immediately.

Article - 18/03/2010

Giant becomes even bigger: Teva acquires ratiopharm

As it turned out, the deal went through quicker than expected. The world’s biggest generic pharmaceuticals producer Teva Pharmaceuticals is set to acquire the Ulm-based competitor ratiopharm for around 3.6 billion euros. Representatives from both companies and other parties involved in the bidding process announced the signing of the purchase agreement in Cologne on 18th March.

Press release - 25/01/2010

Nycomed remains stable at its Singen-based production site

Despite the transfer of around 100 jobs to India the pharmaceutical company Nycomed is maintaining its current staff numbers at its Singen-based production facility. Activities from other Nycomed subsidiaries are being transferred to the Singen-based facility. Jürgen Mahling head of the Singen-based facility also envisages a stable capacity utilisation of production facilities in 2010.

After a successful start of the 2009 business year, Boehringer Ingelheim is expecting their sales growth to outpace the world pharmaceutical market; for the tenth time in succession. As announced by this second-largest German pharmaceuticals producer, the company posted growth in local currency (+ 8.3 per cent) over the previous year in the first six months of 2009. Net sales amounted to 6,388 million euro.